In Vivo Safety and Efficacy Platform for Immunotherapies

A New MHC Class I & II Deficient Platform Humanized With PBMC Has Delayed Xenogeneic GvHD

$0.96 - $9.00

Select Options

Type 1 Diabetes Efficacy Studies

$0.49 - $7.00

Select Options

Genome Scanning

$0.28 - $2.00

Select Options

HuPK A Humanized Platform for therapeutic antibody PK evaluation Field Guide

$1.73 - $10.00

Select Options

Studying CRS In A Diverse Population FAQS

$0.33 - $3.00

Select Options

A New Way to Study Cytokine Release Syndrome

$0.89 - $8.00

Select Options

Studying CRS In A Diverse Population FAQS

Select Options

Oncology JAX Preclinical Models and Services

$1.68 - $13.00

Select Options